Serum CXCL-1 as a predictive biomarker for glucocorticoid resistance in adenoids of patients with adenoid hypertrophy
European Archives of Oto-Rhino-Laryngology · 2025
DOI: 10.1007/s00405-024-09130-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Peiqiang Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China. Hauptthemen laut MEDLINE: Adenoids, Glucocorticoids, Drug Resistance, Chemokine CXCL1. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
PURPOSE: The objective of this study was to elucidate the relationship between adenoid hypertrophy (AH) and glucocorticoid resistance, and to investigate the potential reasons for the suboptimal therapeutic response to intranasal glucocorticoids (INS) in pediatric patients with AH. METHODS: The present study enrolled a cohort of 110 patients diagnosed with AH, all of whom underwent adenoidectomy at Renmin Hospital of Wuhan University between June 2023 and September 2023. Immunohistochemistry and real-time quantitative polymerase chain reaction (RT-qPCR) were employed to assess the levels of inflammatory cytokines, and glucocorticoid receptors (GR, including GRα and GRβ) in adenoidal tissues. The Pearson correlation analysis was employed to ascertain the relationship between the levels of GR and inflammatory cytokines. The receiver operating characteristic (ROC) curve to evaluate the predictive efficacy of inflammatory cytokines in serum in assessing the glucocorticoid sensitivity and the expression of GR. RESULTS: Compared with the AH not associated with allergic rhinitis (AH-nAR) group, patients with AH-AR exhibit heightened eosinophilic inflammation and comorbid symptoms of AR. In patients with AH-nAR and those with poor glucocorticoid response, adenoidal tissues showed lower GRα expression and higher GRβ expression. Furthermore, IL-1β, CXCL-1, and CXCL-2 were simultaneously associated with a negative correlation with GRα, and a positive correlation with GRβ. Compared with IL-1β and CXCL-2, CXCL-1 in serum demonstrated a more significant predictive accuracy in discerning glucocorticoid sensitivity and evaluating the expression of GRα and GRβ. CONCLUSION: In patients with AH-nAR and those with poor glucocorticoid response, evidence of glucocorticoid resistance is observed within adenoidal tissues. Serum CXCL-1 may serve as a potential predictive biomarker for glucocorticoid resistance in AH patients, suggesting that surgical intervention should be more heavily considered for this cohort of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.
- Department of Rhinology and Allergy, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China. xuy@whu.edu.cn.
- Department of Rhinology and Allergy, Renmin Hospital of Wuhan University, Wuhan, China. xuy@whu.edu.cn.
- Hubei Province Key Laboratory of Allergy and Immunology, Wuhan, China. xuy@whu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Fundamental Research Funds for the Central Universities
- Hubei key laboratory opening project
Zitieren
APA
Liu, P., & Xu, Y. (2025). Serum CXCL-1 as a predictive biomarker for glucocorticoid resistance in adenoids of patients with adenoid hypertrophy. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-09130-w
Vancouver
Liu P, Xu Y. Serum CXCL-1 as a predictive biomarker for glucocorticoid resistance in adenoids of patients with adenoid hypertrophy. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-09130-w
BibTeX
@article{Liu2025,
author = {Liu, Peiqiang and Xu, Yu},
title = {Serum CXCL-1 as a predictive biomarker for glucocorticoid resistance in adenoids of patients with adenoid hypertrophy},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2025},
doi = {10.1007/s00405-024-09130-w}
}
EUVIMED